Skip to content

XBIO REPORT

FREE WEEKLY BIOTECH STOCK CATALYST REPORTS
CONTACT

Tag: Sinocare

September 30, 2026

Sinocare Unveils Integrated Chronic Disease Management Solutions at EASD 2024

Innovation at the Heart of Chronic Care At this year’s EASD (European Association for the Study of Diabetes) annual meeting, Sinocare took center stage to showcase its latest advancements in integrated chronic disease management. As global healthcare shifts toward more patient-centric models, Sinocare is positioning itself as a leader in digital health transformation. Integrated Solutions…

Announcements

Chronic Disease, Diabetes Management, Digital Health, EASD, pr-newswire, Sinocare
September 30, 2026

Sinocare Unveils Advanced Chronic Disease Management Solutions at EASD 2024

Revolutionizing Chronic Care Management At the recent EASD (European Association for the Study of Diabetes) 2024 Annual Meeting, global healthcare innovator Sinocare took center stage to showcase its latest advancements in chronic disease management. The company presented a comprehensive suite of integrated solutions designed to help patients and healthcare providers better manage diabetes and related…

Announcements

Chronic Disease, Diabetes Management, Digital Health, EASD 2024, pr-newswire, Sinocare

© XBioReport.com

Disclaimer: This site is for information only. Not investment advice.

Subscribe For A Premium Report To Maximize Your Returns

The FREE bio tech stock catalyst report ONLY includes companies with catalysts within the current week. Often, this may not be enough time to capture the pre-catalyst stock price movements. For MAX RETURNS. Subscribe to a premium report type below and you will receive reports with a longer outlook, allowing you to discover earlier entries to be positioned before a price move happens. Don’t miss out, maximize your return potential!

Choose your outlook window (each priced accordingly)

Get FREE Biotech Stock Catalyst Reports

Email